Volume: 26 Issue: 4
This article documents the first case of TSS associated with the use of a menstrual cup in a 37-year-old woman. The authors also discuss the history of TSS associated with tampon use and the mechanisms by which menstrual cups may also lead to the syndrome. Avian influenza A (H5N1) infection with respiratory failure and meningoencephalitis in a Canadian travellerSince 1997, more than 600 individuals worldwide have been infected with the poultry-originating influenza, H5N1. This report describes the first case of avian influenza A (H5N1) in the Western hemisphere in a 28-year-old woman who had just returned from a trip to Beijing, China. The typical manifestations of H5N1 are described, and signs and symptoms are discussed.
The first European consensus on vaccination in patients with MS has been developed by the European Committee for Treatment and Research in Multiple Sclerosis and the European Academy of Neurology.Medscape Medical News
Deaths among people who have been fully vaccinated remain rare, but older adults and those with compromised immune systems are at much higher risk.
The CDC released data on Thursday showing that unvaccinated Americans are 11 times as likely to die of COVID-19 than vaccinated people, and six times as likely to be infected.
The lower dose of Biktarvy is now approved for pediatric patients weighing at least 14 kg and for adults.FDA Approvals
Rat urine is likely to cause of a recent outbreak of leptospirosis in New York City, a rare bacterial infection that can be transferred from animals to humans via interactions with urine.
AbstractIntroductionThe safety and efficacy of both abobotulinumtoxinA and onabotulinumtoxinA for upper limb spasticity are well established, but head-to-head comparisons are lacking.MethodsDIRECTION is an international, randomized, double-blind, crossover study comparing the safety and efficacy of abobotulinumtoxinA with onabotulinumtoxinA in the management of upper limb spasticity at doses at or near maximum recommended in product labelling. Participants (18 –75 years) will be randomized (1:1) to either one cycle of abobotulinumtoxinA (900U) followed by onabotulinumtoxinA (360U) or vice versa. To maintain blin...
- CBSSports.com site: media |...
The WHO lists antimicrobial resistance as a top ten global health threat, saying that by 2050 it will kill more people than cancer. Could novel vaccines provide new ways to defeat superbugs?
The U.S. Food and Drug Administration (FDA) will allow fully vaccinated Americans to 'mix and match' COVID-19 vaccines and booster shots.
More News: AIDS Vaccine | Allergy & Immunology | Antibiotic Therapy | Bird Flu | Bird Flu (H5N1 Avian Influenza) Vaccine | Children | Disability | Epidemiology | Flu Pandemic | H5N1 | Health | Hepatitis | Hepatitis B | Hepatitis C | Hepatitis Vaccine | HIV AIDS | Hospitals | Infectious Diseases | Influenza | Influenza Vaccine | International Medicine & Public Health | Men | Meningitis | Meningitis Vaccine | Microbiology | MRSA | Outbreaks | Pandemics | Pediatrics | Respiratory Medicine | Staphylococcus Aureus | Study | Superbugs | Toxic Shock Syndrome | Toxicology | Vaccines | Veterinary Vaccinations | Workshops